A new community-based study explores the realities of accessing opioid agonist treatment (OAT) in rural and remote communities, highlighting barriers related to travel, stigma, and treatment flexibility. The findings point to opportunities for technology-enabled care to expand access, increase patient autonomy, and better meet people where they are.
Opioid Agonist Treatment Access in the qathet Region: Final Report
Publication
Posted
February 11, 2026

HIPAA Compliant
SOC 2 Certified




